Pityriasis Rosea in a Confirmed COVID-19 Pediatric Patient
MetadataShow full item record
CitationÖncü, I. N. S., Güler, D., Gürel, G., & Yalçın, G. Ş. (2021). Pityriasis rosea in a confirmed COVID-19 pediatric patient. Actas dermo-sifiliograficas.
On December 31, 2019, the World Health Organization identified a novel coronavirus (SARS-CoV-2) in the city of Wuhan in China that spread very quickly and has to date resulted in the deaths of thousands of people by causing COVID-19 disease. Various Coronavirus disease-19 (COVID-19) associated dermatological manifestations have been reported. Among these, Pityriasis rosea (PR) and PR-like rash have been published previously. During the COVID-19 pandemic, the diagnosis of PR has become more common